141 related articles for article (PubMed ID: 35582374)
1. Adjuvant role of a T-type calcium channel blocker, TTA-A2, in lung cancer treatment with paclitaxel.
Kumari N; Giri PS; Rath SN
Cancer Drug Resist; 2021; 4(4):996-1007. PubMed ID: 35582374
[No Abstract] [Full Text] [Related]
2. T-type calcium channel antagonist, TTA-A2 exhibits anti-cancer properties in 3D spheroids of A549, a lung adenocarcinoma cell line.
Kumari N; Bhargava A; Rath SN
Life Sci; 2020 Nov; 260():118291. PubMed ID: 32810510
[TBL] [Abstract][Full Text] [Related]
3. Antagonistic interaction between TTA-A2 and paclitaxel for anti-cancer effects by complex formation with T-type calcium channel.
Kumari N; Dalal V; Kumar P; Rath SN
J Biomol Struct Dyn; 2022 Apr; 40(6):2395-2406. PubMed ID: 33103598
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-22 enhances chemoresistance of lung adenocarcinoma cells to paclitaxel.
Huang Z; Gao Y; Hou D
Hum Cell; 2020 Jul; 33(3):850-858. PubMed ID: 32452013
[TBL] [Abstract][Full Text] [Related]
5. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
Kraus RL; Li Y; Gregan Y; Gotter AL; Uebele VN; Fox SV; Doran SM; Barrow JC; Yang ZQ; Reger TS; Koblan KS; Renger JJ
J Pharmacol Exp Ther; 2010 Nov; 335(2):409-17. PubMed ID: 20682849
[TBL] [Abstract][Full Text] [Related]
6. Jiegeng Decoction Potentiates the Anticancer Efficacy of Paclitaxel
Chen H; Li G; Liu Y; Lang Y; Yang W; Zhang W; Liang X
Front Pharmacol; 2022; 13():827520. PubMed ID: 35281908
[TBL] [Abstract][Full Text] [Related]
7. Cross-modulation and molecular interaction at the Cav3.3 protein between the endogenous lipids and the T-type calcium channel antagonist TTA-A2.
Cazade M; Nuss CE; Bidaud I; Renger JJ; Uebele VN; Lory P; Chemin J
Mol Pharmacol; 2014 Feb; 85(2):218-25. PubMed ID: 24214826
[TBL] [Abstract][Full Text] [Related]
8. Synergistic anticancer effects of andrographolide and paclitaxel against A549 NSCLC cells.
Yuan H; Sun B; Gao F; Lan M
Pharm Biol; 2016 Nov; 54(11):2629-2635. PubMed ID: 27159496
[TBL] [Abstract][Full Text] [Related]
9. State-dependent properties of a new T-type calcium channel blocker enhance Ca(V)3.2 selectivity and support analgesic effects.
Francois A; Kerckhove N; Meleine M; Alloui A; Barrere C; Gelot A; Uebele VN; Renger JJ; Eschalier A; Ardid D; Bourinet E
Pain; 2013 Feb; 154(2):283-293. PubMed ID: 23257507
[TBL] [Abstract][Full Text] [Related]
10. Blockade of T-type calcium channels prevents tonic-clonic seizures in a maximal electroshock seizure model.
Sakkaki S; Gangarossa G; Lerat B; Françon D; Forichon L; Chemin J; Valjent E; Lerner-Natoli M; Lory P
Neuropharmacology; 2016 Feb; 101():320-9. PubMed ID: 26456350
[TBL] [Abstract][Full Text] [Related]
11. Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter.
Zhang Q; Song Y; Cheng X; Xu Z; Matthew OA; Wang J; Sun Z; Zhang X
Anticancer Res; 2019 Oct; 39(10):5461-5471. PubMed ID: 31570440
[TBL] [Abstract][Full Text] [Related]
12. Combination of Curcumin and Paclitaxel Liposomes Exhibits Enhanced Cytotoxicity Towards A549/A549-T Cells and Unaltered Pharmacokinetics.
Feng X; Pi C; Fu S; Yang H; Zheng X; Hou Y; Wang Y; Zhang X; Zhao L; Wei Y
J Biomed Nanotechnol; 2020 Aug; 16(8):1304-1313. PubMed ID: 33397559
[No Abstract] [Full Text] [Related]
13. Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells.
Klimaszewska-Wiśniewska A; Hałas-Wiśniewska M; Grzanka A; Grzanka D
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495431
[TBL] [Abstract][Full Text] [Related]
14. TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent.
Choe W; Messinger RB; Leach E; Eckle VS; Obradovic A; Salajegheh R; Jevtovic-Todorovic V; Todorovic SM
Mol Pharmacol; 2011 Nov; 80(5):900-10. PubMed ID: 21821734
[TBL] [Abstract][Full Text] [Related]
15. Histone demethylase KDM5A enhances cell proliferation, induces EMT in lung adenocarcinoma cells, and have a strong causal association with paclitaxel resistance.
Xu L; Wu H; Hu X
Acta Biochim Pol; 2021 Jul; 68(4):593-602. PubMed ID: 34270886
[TBL] [Abstract][Full Text] [Related]
16. Synergistic Effect of Graphene Oxide Coated Nanotised Apigenin with Paclitaxel (GO-NA/PTX): A ROS Dependent Mitochondrial Mediated Apoptosis in Ovarian Cancer.
Pal MK; Jaiswar SP; Dwivedi A; Goyal S; Dwivedi VN; Pathak AK; Kumar V; Sankhwar PL; Ray RS
Anticancer Agents Med Chem; 2017; 17(12):1721-1732. PubMed ID: 28443516
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway.
Li C; Zhao X; Yang Y; Liu S; Liu Y; Li X
Med Sci Monit; 2018 May; 24():2750-2757. PubMed ID: 29723165
[TBL] [Abstract][Full Text] [Related]
18. Anticancer Profiling for Coumarins and Related
Baghdadi MA; Al-Abbasi FA; El-Halawany AM; Aseeri AH; Al-Abd AM
Molecules; 2018 Apr; 23(5):. PubMed ID: 29701706
[TBL] [Abstract][Full Text] [Related]
19. Coadministration of a tumor-penetrating peptide improves the therapeutic efficacy of paclitaxel in a novel air-grown lung cancer 3D spheroid model.
Gupta SK; Torrico Guzmán EA; Meenach SA
Int J Cancer; 2017 Nov; 141(10):2143-2153. PubMed ID: 28771722
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Anticancer Effect of a Combination of Paclitaxel and 5-Demethylnobiletin Against Lung Cancer Cell Line In Vitro and In Vivo.
Tan KT; Li S; Li YR; Cheng SL; Lin SH; Tung YT
Appl Biochem Biotechnol; 2019 Apr; 187(4):1328-1343. PubMed ID: 30229430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
